Discovery to Decision: Virtual Assays for Drug Target Ranking and Derisking


Wednesday, 27th May 2026

AI investment trends and the opportunities in Alberta


Tuesday, 14th Apr 2026

From Protocol to EDC in Minutes: How AI Is Rewriting Study Start-Up


Tuesday, 24th Mar 2026

Breakfast Executive Exchange: Is Hotel Tech Overhyped? Market Signals and the 2027 Outlook


Wednesday, 22nd Apr 2026

Breakfast Executive Exchange: Is Hotel Tech Overhyped? Market Signals and the 2027 Outlook taking place in Amsterdam on Wednesday 22nd April 2026 from 8am.

Cutting through the noise to drive measurable value

  • Market outlook: investment signals, consolidation, and risk priorities
  • AI – separating hype from tangible results
  • Establishing a use case – the difference between failure and success
  • Investment priorities: where should you invest?

Why attend?

  • Read the real market signals: which metrics and buyer behaviors are separating enduring solutions from short-lived hype.
  • Budgets under pressure: where investment is accelerating (commercial, automation, data/AI, payments) and where consolidation is inevitable.
  • Platform vs. point solutions: how integration, interoperability, and vendor lock-in are reshaping procurement and partnerships.
  • From pilots to proof: practical criteria to scale, renegotiate, or sunset tech—plus what “next” looks like for 2026 planning.

Join this expert-led, peer-to-peer deep-dive session to hear from those in the know. Take back to your business an understanding of what it takes to succeed and lessons learned from those who have been there, done that.

Delegates must pre-register interest prior to the day of the event.

Overview

The traditional separation between Risk and Finance is dissolving. From Treasury and ALM models to IFRS 9 and stress testing, AI is accelerating a structural convergence that demands new approaches to governance, accountability, and organisational design. At the same time, UK and EU regulators — through PRA SS 1/23, the ECB’s AI thematic review, the EU AI Act, and DORA — are raising the bar on what they expect from institutions navigating this shift.

Join us for this exclusive, invitation-only roundtable where Sree Kumar Gullapalli, Director of Treasury Risk and Analytics at Santander UK, helps lead a practitioner-led conversation on the defining governance challenge facing banking today.

Agenda

18.00 Champagne Reception & Networking

18:30 Guests seated and welcome by FDE

18:50 Introductory address by Genpact

19.00 Keynote presentation from Santander

19.15 Moderated discussion and Q&A

19:50 Break & Networking

20:05 Dinner is served, informal discussion amongst guests

21:25 Closing remarks

21:30 End of briefing & further networking

Decom: Delivering the next phase of value for oil and gas assets


Thursday, 26th Mar 2026

Beauty from within: Potential of B. breve M-16V in Skin Health


Tuesday, 10th Mar 2026

Overview

Finance leaders today face the challenge of steering their organizations through complexity while enabling smarter, faster decisions. At this exclusive, invitation-only CFO Roundtable in Milan, Alanna Abrahamson, EVP & CFO of Marelli, will share how her team is leveraging digital tools, advanced analytics, and process modernization to create a finance function that is agile, insight-driven, and ready for the future.

The discussion will explore practical steps to embed data intelligence into planning and performance, accelerate decision cycles, and balance compliance with innovation, offering participants actionable ideas to strengthen resilience and strategic impact.

 

Agenda

18.00 Champagne Reception & Networking

18:30 Guests seated and welcome by FDE

18:50 Introductory address by Genpact

19.00 Keynote presentation from Alanna Abrahamson, EVP & CFO, Marelli

19.15 Moderated discussion and Q&A

19:50 Break & Networking

20:05 Dinner is served, informal discussion amongst guests

21:25 Closing remarks

21:30 End of briefing & further networking

Unlock value with MarketScan’s advanced data linking


Thursday, 05th Mar 2026 - Tuesday, 27th Jan 2026

Future Proofing Cell & Gene Therapy: Strategies to Secure Your Leukapheresis Supply Chain


Wednesday, 11th Mar 2026